
Molecular Pharmacology Program
The Daniel Heller Lab
Research

Professor
Cancer Nanomedicine Laboratory
We are a biomedical engineering laboratory that develops nanotechnologies to advance breakthroughs in the research, diagnosis, and treatment of cancer and allied diseases. We develop drug delivery technologies to target therapies to disease sites, advanced diagnostics to detect disease at earlier stages, and nanosensors to accelerate the discovery of new therapies. Please check out our recent innovations using the “View Lab Overview” button below…
Research Projects
Inside My Lab: Daniel Heller

Featured News



Publications
Highlighted in: MSK News and Nature Materials News & Views
M Kim, C Chen, P Wang, JJ Mulvey, Y Yang, C Wun, M Antman-Passig, H-B Luo, S Cho, K Long-Roche, LV Ramanathan, A Jagota, M Zheng, Y Wang, DA Heller*. “Machine-Learning-Based Detection of an Ovarian Cancer Disease Fingerprint from Serum via Quantum Defect-Modified Carbon Nanotube Arrays.” Nature Biomedical Engineering (2022). https://www.mskcc.org/news/sensor-sniffs-cancer-using-artificial-intelligence
Z Yaari, Y Yang, E Apfelbaum, C Cupo, A Settle, Q Cullen, W Cai, K Long Roche, DA Levine, M Fleisher, L Ramanathan, M Zheng, A Jagota, DA Heller*. ”A Perception-Based Machine-Perception Nanosensor Platform to Detect Cancer Biomarkers.” Science Advances 7 (2021) eabj0852. MSK News: https://www.mskcc.org/news/detect-ovarian-cancer-early-researchers-look-nanotechnology
J Budhathoki-Uprety, J Shah, JA Korsen, AE Wayne, TV Galassi, JR Cohen, JD Harvey, PV Jena, LV Ramanathan, EA Jaimes, DA Heller*. “Synthetic Molecular Recognition Nanosensor Paint for Microalbuminuria.” Nature Communications 10 (2019) 3605.
[MSK News: https://www.mskcc.org/news/science-meets-art-produce-diagnostic-test-us…]
People

Daniel A. Heller, PhD
Member, Molecular Pharmacology Program, SKI
Professor
- Biomedical engineer Daniel Heller is Head of the Cancer Nanotechnology Laboratory, which invents disruptive technologies to revolutionize the diagnosis and treatment of cancer and allied diseases.
- PhD, University of Illinois at Urbana-Champaign
- [email protected]
- Email Address
- 646-888-3419
- Office Phone
- Download CV
- PDF File
Members


- PhD in Engineering and Bioengineering
- 646-888-3416
- Lab Phone

- 646-888-3416
- Lab Phone

- BS in Chemistry from The College of New Jersey, Ewing NJ (2019)

Lab Head

Postdoctoral Research Fellow

Graduate Student, CUNY Chemistry PhD Program

CUNY Chemistry/Nanotechnology PhD Program Student

Tri-institutional PhD Program in Chemical Biology

Graduate Student, Weill Cornell PBSB PhD Program

Senior Research Technician

Assistant Attending, Anesthesiology and Critical Care

Pharmacology PhD Graduate Student

Graduate Student, Weill Cornell PBSB PhD Program

Postdoctoral Research Associate

Assistant Attending L1, Radiation Oncology

Postdoctoral Research Associate

Undergraduate Researcher

Graduate Student, Weill Cornell Pharmacology PhD Program

BCMB PhD Program Student

Lab Manager
MSK Bridge Program Scholar

Graduate Student (Weill Cornell Medicine; Pharmacology PhD Program)

Tri-institutional PhD Program in Chemical Biology

Senior SKI Administrative Assistant



- PhD in Chemistry

- PhD in Nano Biosensing


- BS in Biochemistry
- PhD, Weill Graduate School of Medical Sciences, Cornell University

- Massachusetts Institute of Technology 2013

- 646-888-3416
- Lab Phone



- PhD in Chemical Engineering


- BS in Biochemistry from University of Delaware (2014)
- BS in Biology (Cell Molecular and Genetics) from University of Delaware (2014)

- BA in Chemistry

- PhD in Pharmaceutical and Pharmacological Sciences

- BSc in Biochemical Engineering
- MSc in Chemical Engineering
- PhD in Chemical Engineering
Lab Alumni

Clinical Nurse

Graduate Student, Weill Cornell Pharmacology PhD Program

Resident in Anesthesiology, Bonica Scholars Program, University of Washington

Associate Consultant, Triangle Insights Group, LLC

Assistant Professor, North Carolina State University

Graduate Student, Columbia University

Equity Research Associate - Medical Devices at Oppenheimer & Co. Inc

Platform Scientist, Zoetis Denmark

Managing Director, Investor Communications at LifeSci Advisors LLC

Scientist I, Nanotechnology Characterization Laboratory, National Cancer Institute, National Institutes of Health

Analyst, Deerfield

Consultant

CTO, Lime Therapeutics, Inc.

Healey ALS Scholar at Columbia University Irving Medical Center

Attending Physician, Division of Oncology, Children's Hospital of Philadelphia

Scientist I, SalioGen Therapeutics

Associate Medical Writer – PPD

Business Development at Resilience

Associate Professor, University of Rhode Island

Assistant Professor, Faculty of Biomedical Engineering, Technion-Israel Institute of Technology
Graduate Student, GSK PhD Program

Sr. Assoc. - Prescient Healthcare Group

Patent Agent at Smith Baluch LLP

Assistant Professor, CCNY

Assistant Professor, School of Pharmacy, Department of Medicine, Hebrew University of Jerusalem, Israel
Lab Affiliations
Achievements
- American Institute for Medical and Biological Engineering (AIMBE) Fellow (2021)
- Pharmacology Teaching and Mentoring Award, Weill Cornell Graduate School (2020)
- American Cancer Society Research Scholar (2018)
- NSF CAREER Award (2018)
- Pershing Square Sohn Prize for Young Innovators in Cancer Research (2017)
Read more
- NIH Director’s New Innovator Award (2012)
- Damon Runyon Cancer Research Foundation Postdoctoral Fellowship (2010)
- Beckman Institute Graduate Fellowship (2006)
Lab News & Events
Accolades
Team Recognitions
-
Congratulations to Mijin Kim on winning the 2023 MSK Postdoctoral Researcher Award!
-
Congratulations to Dr. Mijin Kim - NIH K99/R00 awardee!
-
Congratulations to Naxhije Berisha - Tow Fellowship Awardee!
-
Congratulations to Dr. Mijin Kim - Kravis WiSE Postdoctoral Fellowship Winner!
-
Congratulations to Stephen Ruiz - awarded the MERIT Mandel Graduate Fellowship!
-
Congratulations to Magdalini Panagiotakopoulos – Tow Postdoctoral Fellowship Awardee!
-
Congratulations to Dr. Mijin Kim – MIT Technology Review 35 Under 35 Innovator!
-
Congratulations to Magdalini Panagiotakopoulos on winning the Controlled Release Society Poster Prize
Get in Touch
-
Lab Head Email
-
Office Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Daniel A. Heller discloses the following relationships and financial interests:
-
Concarlo Holdings, LLC
Provision of Services -
Goldilocks Therapeutics Inc.
Fiduciary Role/Position; Ownership / Equity Interests; Provision of Services -
Lime Therapeutics, Inc.
Fiduciary Role/Position; Ownership / Equity Interests; Provision of Services (uncompensated) -
Mediphage Bioceuticals, Inc.
Ownership / Equity Interests; Provision of Services (uncompensated)
-
Nanorobotics, Inc.
Ownership / Equity Interests -
Nirova BioSense, Inc.
Ownership / Equity Interests -
Resident Diagnostics, Inc.
Ownership / Equity Interests; Provision of Services (uncompensated)
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].